1-4 of 4
Stacey A Cranert
Close
Sort by
Journal Articles

A Tumor-Bearing Murine Xenograft Model As a Bioassay for Assessing CAR-T Product Potency Shows Positive Predictive Value for Clinical Performance

Stacey A Cranert, Hubert Tseng, Karl Marquez, Benjamin S Cho, Andrew Bacong, Danny Mendoza, Garrett Arauz, Nick DeMarco, Mona Connerney, Julia Coronella, Devon J Shedlock
Journal: Blood
Blood (2023) 142 (Supplement 1): 2293.
https://doi.org/10.1182/blood-2023-189837
Published: 2023
Journal Articles

Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Bhagirathbhai Dholaria, Mehmet H. Kocoglu, Andrew Kin, Adam S. Asch, Aravind Ramakrishnan, Carlos Bachier, Tulio E. Rodriguez, Leyla Shune, Katherine McArthur, Joanne McCaigue, Samuel DePrimo, Chris Martin, Sabrina Haag, Maggie Zhang, Hamid Namini, Ellen Christie, Rajesh Belani, Stacey A Cranert, Julia Coronella, Devon J Shedlock, Caitlin L. Costello
Journal: Blood
Blood (2023) 142 (Supplement 1): 3479.
https://doi.org/10.1182/blood-2023-182430
Published: 2023
Journal Articles

Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control

Hubert Tseng, Yan Zhang, Stacey A Cranert, Maximilian Richter, Karl Marquez, Jing Qiu, Benjamin Cho, Yening Tan, Min Tong, Christine Domingo, Leslie Weiss, Elvira Argus, Jessica Sparks, Eric M. Ostertag, Julia Coronella, Devon J Shedlock
Journal: Blood
Blood (2021) 138 (Supplement 1): 4802.
https://doi.org/10.1182/blood-2021-154034
Published: 2021
Journal Articles

Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable

Stacey A Cranert, PhD, Maximilian Richter, PhD, Min Tong, MS, Leslie Weiss, MS, Yening Tan, MS, Eric M. Ostertag, MD PhD, Julia Coronella, PhD, Devon J Shedlock, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4445.
https://doi.org/10.1182/blood-2019-131839
Published: 2019